Table 3.
Associations of MUC19 mutation status with clinical characters in our cohort.
| Parameter | MUC19 wild-type | MUC19 mutant | P value |
|---|---|---|---|
| Age | 1.000 | ||
| <65 | 10 | 8 | |
| ≥ 65 | 9 | 6 | |
| Sex | 0.416 | ||
| Male | 13 | 12 | |
| Female | 6 | 2 | |
| BMI | 0.455 | ||
| <24 | 12 | 11 | |
| ≥ 24 | 7 | 3 | |
| Performance status | 0.416 | ||
| 0–1 | 13 | 12 | |
| ≥2 | 6 | 2 | |
| Smoking status | 0.286 | ||
| Former/Current | 9 | 10 | |
| Never | 10 | 4 | |
| Histology | 0.854 | ||
| Adenocarcinoma | 10 | 6 | |
| Squamous cell carcinoma | 8 | 7 | |
| Other | 1 | 1 | |
| Stage | 0.257 | ||
| III | 4 | 6 | |
| IV | 15 | 8 | |
| Metastasis site | |||
| Lymph node (yes/no) | 16/3 | 9/5 | 0.238 |
| Lung (yes/no) | 10/9 | 4/10 | 0.286 |
| Bone (yes/no) | 5/14 | 4/10 | 1.000 |
| Liver (yes/no) | 1/18 | 1/13 | 1.000 |
| Brain (yes/no) | 3/16 | 3/11 | 1.000 |
| Adrenal (yes/no) | 3/16 | 1/13 | 0.62 |
| PD-L1 | |||
| <1% | 4 | 4 | 0.716 |
| ≥1% | 7 | 6 | |
| Unknown | 8 | 4 | |
| TMB | 0.363 | ||
| <10 mut/Mb | 17 | 10 | |
| ≥10 mut/Mb | 2 | 4 |